Actualités

Autodesk currently trades at $246.30 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.

Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.

POWL's fiscal Q3 earnings and revenues miss estimates, even as record orders and a $2.4 billion backlog strengthen its outlook.

EME's record backlog, AI infrastructure demand and acquisitions are strengthening growth, as it lifts its 2026 revenue and earnings outlook.

Space stocks are surging ahead of SpaceX's first-ever public earnings report, but with prediction markets flagging a 70% chance of a miss and a 911-million-share lockup expiry days away, traders face a tense setup that could cut either way.

Fidelity National tops Q2 EPS estimates as Banking Solutions fuels growth and margins improve, but the company lowers its full-year revenue and earnings outlook.

Block heads into the Q2 earnings release with 20% gross profit growth targeted, Cash App and Square momentum, and bitcoin volatility shaping the outlook.

Pfizer beats Q2 earnings and revenue estimates, raises the low end of its 2026 sales outlook, but lowers expectations for COVID product revenues.

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 10.2% year on year to $16.99 billion. Its non-GAAP profit of $3.65 per share was 1.2% above analysts’ consensus estimates.

BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.

PHIN misses Q2 earnings estimates despite higher sales as employee costs and product mix weigh on margins.

XOM's Q2 earnings missed estimates, but strong production, oil prices and balance sheet strength support its outlook.

Avis Budget's Q2 earnings miss exposed soft rental demand, while fleet cuts, record utilization and reaffirmed 2026 EBITDA guidance supported margins.

An analysis of the last seven years of Tesla earnings calls shows just little attention Musk pays to Tesla's car business.

NRG's Q2 earnings miss estimates, but revenues climb 11% as lower operating costs and shareholder returns support performance.

Free cash flow is negative while the cloud build runs, and that is the whole question for anyone weighing the stock today.

ODFL's earnings beat, pricing power and strong balance sheet support momentum, but its premium valuation leaves little room for execution missteps.

There have been several standouts in the cycle so far, including Microsoft, Bloom Energy, and EMCOR Group, all of which have seen nice momentum in the days following their robust earnings releases.

Paul Mueller's Q2 revenues jump 29% y/y, but lower margins weigh on earnings as strong pharmaceutical demand and a healthy backlog support the results.

DDOG heads into Q2 with strong momentum as AI products, platform expansion and a strategic acquisition support growth ahead of earnings.

Analysts’ expectations for a sharp year over year jump in earnings and revenue at EOG Resources (EOG) ahead of its upcoming quarterly report have put the stock in focus, even after a recent consensus EPS trim. See our latest analysis for EOG Resources. EOG Resources’ recent momentum is clear, with the share price up 11.39% over the past 30 days and a 35.81% year to date share price return. Meanwhile, the 5 year total shareholder return of 168.41% highlights how longer term holders have been...

TransMedics Group (TMDX) heads into a busy early August, with Q2 2026 results and an earnings call scheduled for August 4 after the market close, drawing fresh attention to the stock. See our latest analysis for TransMedics Group. Recent trading in TransMedics Group reflects this renewed attention, with a 1 day share price return of 6.6% and a 30 day share price return of 18.4%, even as the year to date share price return is down 33.5% and the 1 year total shareholder return is down 35.1%...

FISV's Q2 earnings results are set for Aug. 6, with revenues and profit expected to fall y/y amid weaker financial solutions and rising investment costs.

Rockwell Automation tops Q3 earnings and revenue estimates as margin expansion boosts results, prompting it to raise its fiscal 2026 outlook.

Diamondback Energy (NASDAQ:FANG) said its second-quarter operational performance and view of global oil inventories support a potential path toward low-single-digit organic production growth in 2027, while management emphasized it intends to retain flexibility amid commodity-market volatility. Chie

Cipher Mining (NASDAQ:CIFR) said its second-quarter 2026 business update reflected continued progress in its transition toward developing and operating data centers for high-performance computing, or HPC, customers. The company highlighted an accelerated delivery at its Black Pearl campus, an $810 m

Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue

WPM is set to report Q2 results on Aug. 6 as higher gold and silver prices are expected to drive sharp sales and earnings growth.

Vertex's Q2 earnings miss estimates, but revenues beat. It lifts its 2026 sales outlook, and sees growing contributions from newer products.

Tower Semiconductor (NASDAQ:TSEM) has reported second quarter results above Wall Street expectations, including record revenue and profitability as the chipmaker continues to benefit from demand across its key business units. The company reported adjusted earnings per share of $0.88 for the...